Barely Significant
← all excerpts

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.

PLoS One · 2015 · PMC4470658 · PMID 26083390

1
hedged sentence
closest p
boldest claim

The sentences

This again showed no significant change in EphA7 expression in support of the flow cytometric data; there was an increase in EphA5 expression in EphA2 knockout MLL-A9 when compared to wild type MLL-AF9 leukemic cells, although this was variable and did not reach statistical significance ( Fig 6B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.